Jen Monnier is an intern at Spectrum. She is a journalist in New York City, covering medicine, technology and ecosystems. She’s also a graduate student at New York University’s Science, Health and Environmental Reporting program.
Jen Monnier
From this contributor
Early interventions, explained
The accepted wisdom in autism research holds that early intervention offers the best promise for an autistic child’s well-being. But how effective are these therapies?
Multipart device monitors various senses in babies
A new assemblage of tools precisely gauges a baby’s biological response to sights, sounds and tactile stimuli all at once.
Multipart device monitors various senses in babies
By
Jen Monnier
17 August 2018 | 2 min read
New consortium may create projects, funding for autism research
A newly formed group of leaders from the U.S. National Institutes of Health (NIH) is poised to generate funding opportunities for child health research, including autism science.
New consortium may create projects, funding for autism research
By
Jen Monnier
2 August 2018 | 3 min read
Glowing capsule illuminates problems in gut
An ingestible electronic capsule enables researchers to instantaneously detect molecules associated with gastrointestinal issues.
Explore more from The Transmitter
From friend to foe: How the brain updates feelings toward others
A specific hippocampus-to-amygdala pathway reassigns emotional valence to a known individual, whereas the hippocampus’s own representation of that individual’s identity remains stable.
From friend to foe: How the brain updates feelings toward others
A specific hippocampus-to-amygdala pathway reassigns emotional valence to a known individual, whereas the hippocampus’s own representation of that individual’s identity remains stable.
By
Natalia Mesa
9 July 2026 | 5 min read
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
By
Kenneth Harris
9 July 2026 | 9 min read
Neuropathologist not guilty of research misconduct, says university probe
The investigation determined that seven papers by corresponding author Adriano Aguzzi have “scientifically significant” errors, which Aguzzi attributes to his former students.
Neuropathologist not guilty of research misconduct, says university probe
The investigation determined that seven papers by corresponding author Adriano Aguzzi have “scientifically significant” errors, which Aguzzi attributes to his former students.
By
Dalmeet Singh Chawla
8 July 2026 | 5 min read